Arthur Bedrosian - Lannett President CEO, Director
| LCIDelisted Stock | USD 0.03 0.0004 1.51% |
CEO
Mr. Arthur P. Bedrosian, J.D. is no longer Chief Executive Officer, Director of the Company effective January 2, 2018. Previously, he served as the Companys Vice President of Business Development from January 2002 to April 2002. Mr. Bedrosian was elected as a Director in February 2000 and served to January 2002. Mr. Bedrosian was reelected a Director in January 2006. Mr. Bedrosian has operated generic drug manufacturing, sales and marketing businesses in the healthcare industry for many years. Prior to joining the Company, from 1999 to 2001, Mr. Bedrosian served as President and Chief Executive Officer of Trinity Laboratories, Inc., a medical device and drug manufacturer. Mr. Bedrosian also operated Pharmaceutical Ventures Ltd, a healthcare consultancy, Pharmeral, Inc. a drug representation company selling generic drugs and Interal Corporationrationration, a computer consultancy to Fortune 100 companies since 2014.
| Age | 70 |
| Tenure | 10 years |
| Phone | 215 333 9000 |
| Web | https://www.lannett.com |
Lannett Management Efficiency
The company has Return on Asset of (0.078) % which means that on every $100 spent on assets, it lost $0.078. This is way below average. Lannett's management efficiency ratios could be used to measure how well Lannett manages its routine affairs as well as how well it operates its assets and liabilities.The company has 614.95 M in debt with debt to equity (D/E) ratio of 5.03, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Lannett Company has a current ratio of 2.35, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Lannett until it has trouble settling it off, either with new capital or with free cash flow. So, Lannett's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lannett Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lannett to invest in growth at high rates of return. When we think about Lannett's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 11 records | CEO Age | ||
| Brendan Kennedy | Tilray Inc | 44 | |
| Keith Kendall | Aquestive Therapeutics | 66 | |
| Richard Nanula | Lucy Scientific Discovery | 63 | |
| Arthur Przybyl | ANI Pharmaceuticals | 61 | |
| Scott Tarriff | Eagle Pharmaceuticals | 64 | |
| Irwin Simon | Tilray Inc | 66 | |
| James Hall | Lifecore Biomedical | 61 | |
| Daniel Myers | Alimera Sciences | 63 | |
| Nikhil Lalwani | ANI Pharmaceuticals | 46 | |
| Peter Hecht | Ironwood Pharmaceuticals | 53 | |
| Mark Mallon | Ironwood Pharmaceuticals | 55 | |
Management Performance
| Return On Asset | -0.078 |
Lannett Company Leadership Team
Elected by the shareholders, the Lannett's board of directors comprises two types of representatives: Lannett inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lannett. The board's role is to monitor Lannett's management team and ensure that shareholders' interests are well served. Lannett's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lannett's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Drabik, Lead Independent Director | ||
| Melissa Rewolinski, Independent Director | ||
| Paul Taveira, Independent Director | ||
| Patrick LePore, Non-Executive Independent Chairman of the Board | ||
| Timothy Crew, Chief Executive Officer, Director | ||
| Albert Paonessa, Director | ||
| Maureen Cavanaugh, Senior Vice President and Chief Commercial Operations Officer | ||
| Kevin Smith, Sr. VP of Sales and Marketing | ||
| Rohit Desai, Vice President of New Product Strategy | ||
| Alicia Evolga, Vice President - Marketing | ||
| John Kozlowski, Chief Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
| Kristie Stephens, Chief Compliance Officer, Vice President | ||
| Arthur Bedrosian, President CEO, Director | ||
| Kristin Arnold, Vice President - Research and Development | ||
| Jeffrey Farber, Chairman of the Board | ||
| Martin Galvan, CFO, Vice President - Finance, Treasurer | ||
| Grant Brock, Vice President - Operations | ||
| Mahendra Dedhiya, Vice President of Scientific Affairs | ||
| Robert Ehlinger, Vice President - Logistics, Chief Information Officer | ||
| John Chapman, Independent Director | ||
| Michael Bogda, President | ||
| James Maher, Independent Director | ||
| John Abt, Vice President and Chief Quality and Operations Officer | ||
| Samuel Israel, Vice President General Counsel, Chief Legal Officer |
Lannett Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lannett a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.078 | |||
| Profit Margin | (0.62) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 578.81 M | |||
| Shares Outstanding | 10.77 M | |||
| Shares Owned By Insiders | 14.26 % | |||
| Shares Owned By Institutions | 38.90 % | |||
| Number Of Shares Shorted | 1.24 M | |||
| Price To Earning | 92.21 X | |||
| Price To Book | 1.84 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Lannett Company information on this page should be used as a complementary analysis to other Lannett's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Lannett Stock
If you are still planning to invest in Lannett Company check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lannett's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |